Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Danielle Schlosser, PhD

    TitleAssistant Professor
    SchoolUCSF School of Medicine
    Address401 Parnassus Ave, LangPorter
    San Francisco CA 94143
    vCardDownload vCard

      Collapse Biography 
      Collapse Awards and Honors
      NIH/NIMH 2013 - 2018Career Development Award (K23 MH097795)
      NIH/NIMH2013 - 2016Clinical Trial Planning Award (R34 MH100399)
      UCSF, CTSI2014 - 2015Digital Health Research Award
      UCSF, CTSI2013 - 2014Catalyst Award in Digital Health
      UCSF, CTSI2012 - 2013Mobile Health Research Award

      Collapse Overview 
      Collapse Overview
      Dr. Danielle Schlosser is an Assistant Professor in the Department of Psychiatry at UCSF and the Director of the NIMH-funded, Digital Research Intervention for Volitional Enhancement (DRIVE) lab. The focus of her research is on harnessing digital health strategies and the latest behavioral neuroscience of motivation to improve the lives of young people living with schizophrenia. Dr. Schlosser is currently conducting research on a newly designed mobile app called, PRIME (Personalized, Real-time Intervention for Motivational Enhancement). The focus of PRIME is on harnessing the intact desire young people with schizophrenia have to improve their lives by giving them the necessary support and reinforcement to be successful.

      Collapse ORNG Applications 
      Collapse Websites
      Collapse In The News
      Collapse NIH Awarded Grants
      Collapse Featured Videos

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Schlosser DA, Fisher M, Gard D, Fulford D, Loewy RL, Vinogradov S. Motivational deficits in individuals at-risk for psychosis and across the course of schizophrenia. Schizophr Res. 2014 Sep; 158(1-3):52-7.
        View in: PubMed
      2. David J. Miklowitz, Mary P. O’Brien, Danielle A. Schlosser, Jean Addington, Kristin A. Candan, Catherine Marshall, Isabel Domingues, Barbara C. Walsh, Jamie L. Zinberg, Sandra D. De Silva, Michelle Friedman-Yakoobian, Tyrone D. Cannon . Family-Focused Treatment for Adolescents and Young Adults at High Risk for Psychosis: Results of a Randomized Trial. Journal of the American Academy of Child & Adolescent Psychiatry. 2014.
      3. Miklowitz DJ, O'Brien MP, Schlosser DA, Addington J, Candan KA, Marshall C, Domingues I, Walsh BC, Zinberg JL, De Silva SD, Friedman-Yakoobian M, Cannon TD. Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial. J Am Acad Child Adolesc Psychiatry. 2014 Aug; 53(8):848-58.
        View in: PubMed
      4. Schlosser DA. In people with ultra high risk symptoms, risk of transition to psychotic disorders is highest in the first 2 years. Evid Based Ment Health. 2014 May; 17(2):39.
        View in: PubMed
      5. Fisher M, Loewy R, Carter C, Lee A, Ragland JD, Niendam T, Schlosser D, Pham L, Miskovich T, Vinogradov S. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophr Bull. 2015 Jan; 41(1):250-8.
        View in: PubMed
      6. Fisher M, Loewy R, Hardy K, Schlosser D, Vinogradov S. Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia. Annu Rev Clin Psychol. 2013; 9:435-63.
        View in: PubMed
      7. Schlosser DA, Pearson R, Perez VB, Loewy RL. Environmental Risk and Protective Factors and Their Influence on the Emergence of Psychosis. Adolesc Psychiatry (Hilversum). 2012 Apr; 2(2):163-171.
        View in: PubMed
      8. Schlosser DA, Miklowitz DJ, O'Brien MP, De Silva SD, Zinberg JL, Cannon TD. A randomized trial of family focused treatment for adolescents and young adults at risk for psychosis: study rationale, design and methods. Early Interv Psychiatry. 2012 Aug; 6(3):283-91.
        View in: PubMed
      9. Schlosser DA, Jacobson S, Chen Q, Sugar CA, Niendam TA, Li G, Bearden CE, Cannon TD. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull. 2012 Nov; 38(6):1225-33.
        View in: PubMed
      10. Schlosser DA, Zinberg JL, Loewy RL, Casey-Cannon S, O'Brien MP, Bearden CE, Vinogradov S, Cannon TD. Predicting the longitudinal effects of the family environment on prodromal symptoms and functioning in patients at-risk for psychosis. Schizophr Res. 2010 May; 118(1-3):69-75.
        View in: PubMed
      11. Stuart BK, Schlosser DA. Multifamily group treatment for schizophrenia. Int J Group Psychother. 2009 Jul; 59(3):435-40.
        View in: PubMed
      Danielle's Networks
      Related Concepts
      Derived automatically from this person's publications.
      People in Profiles who have published with this person.
      Related Authors
      People who share related concepts with this person.
      Back to TOP